Back to Search
PETER STEINHERZ, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1952373177Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
103874(NM)
Research & Publications (20)
Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia.
PMID 17805046·J Pediatr Hematol Oncol·2007
5-case
Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study.
PMID 19660727·Biol Blood Marrow Transplant·2009
8-other
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
PMID 19652076·J Clin Oncol·2009
3-trial
Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.
PMID 18781564·Int J Cancer·2008
8-other
Ten-year survival of children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
PMID 18569638·Leuk Lymphoma·2008
1-meta
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
PMID 18039957·Blood·2008
2-rct
The use of preoperative chemotherapy in Wilms' tumor with contained retroperitoneal rupture.
PMID 17848255·J Pediatr Surg·2007
8-other
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
PMID 16622268·J Clin Oncol·2006
3-trial
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
PMID 15496649·J Clin Pharmacol·2004
8-other
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.
PMID 15087948·J Pediatr Hematol Oncol·2004
3-trial
Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.
PMID 14999294·Leukemia·2004
8-other
Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood.
PMID 14669284·Cancer·2003
5-case
A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia.
PMID 14513046·Leukemia·2003
3-trial
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.
PMID 12972803·J Pediatr Hematol Oncol·2003
4-observational
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
PMID 12697887·J Clin Oncol·2003
3-trial
Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers.
PMID 12692800·Med Pediatr Oncol·2003
4-observational
Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group.
PMID 12481889·Leuk Lymphoma·2002
3-trial
Pythium insidiosum pleuropericarditis complicating pneumonia in a child with leukemia.
PMID 12203186·Clin Infect Dis·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-7951
Quick Facts
- NPI
- 1952373177
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile